Based on the scRNAseq results correlating OPN expression with IFNγ signaling pathways, we hypothesized that OPN may contribute to ‘adaptive immune resistance’ as PD-L1, in which tumor-immune interactions induce a counterregulatory program that protects tumor cells from immune clearance. The gene discussed is SPP1; the disease is neoplasm.